Nigel McCracken

Chief Tech/Sci/R&D Officer at BERGENBIO ASA

Health Technology

Consumer Services

Finance

Profile

Nigel McCracken is currently the Chief Scientific Officer at BerGenBio ASA and the Chief Operating Officer at Virax Biolabs Group Ltd.
He previously worked as the Executive Director & VP-Translational Medicine at Debiopharm International SA from 2014 to 2019.
He also held a position as COO and Senior VP-Discovery & Early Development at NuCana Plc.
Dr. McCracken received his undergraduate degree from the University of Strathclyde and his graduate degree from King's College London.

Nigel McCracken active positions

Companies	Position	Start
BERGENBIO ASA	Chief Tech/Sci/R&D Officer	01/01/2021
VIRAX BIOLABS GROUP LIMITED	Chief Operating Officer	01/09/2023

All active positions of Nigel McCracken

Former positions of Nigel McCracken

Companies	Position	End
Debiopharm International SA Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland.	Director/Board Member	01/04/2019
NUCANA PLC	Chief Operating Officer	-

See the detail of Nigel McCracken's experience

Training of Nigel McCracken

University of Strathclyde	Undergraduate Degree
King's College London	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Nigel McCracken's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	3
BERGENBIO ASA	Health Technology
NUCANA PLC	Health Technology
VIRAX BIOLABS GROUP LIMITED	Finance

Private companies	1
Debiopharm International SA Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland.	Health Technology